Revenue - Jbm (Healthcare) Ltd (HKEX:2161) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 0.86 HKD -2.27%

Updated:

Jbm (Healthcare) Ltd
Revenue

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Jbm (Healthcare) Ltd
Revenue Peer Comparison

U

3933

S

1177

C

570

C

3320

HCM

Company		Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Jbm (Healthcare) Ltd HKEX:2161	Revenue HK$520.3m	CAGR 3-Years 11%	CAGR 5-Years 15%	CAGR 10-Years N/A
U	United Laboratories International Holdings Ltd HKEX:3933	Revenue ¥13.7B	CAGR 3-Years 16%	CAGR 5-Years 13%	CAGR 10-Years 9%
S	Sino Biopharmaceutical Ltd HKEX:1177	Revenue ¥26.2B	CAGR 3-Years 3%	CAGR 5-Years 5%	CAGR 10-Years 13%
C	China Traditional Chinese Medicine Holdings Co Ltd HKEX:570	Revenue ¥18.1B	CAGR 3-Years 7%	CAGR 5-Years 10%	CAGR 10-Years 29%
C	China Resources Pharmaceutical Group Ltd HKEX:3320	Revenue HK$244.7B	CAGR 3-Years 7%	CAGR 5-Years 5%	CAGR 10-Years N/A
	HUTCHMED (China) Ltd LSE:HCM	Revenue $838m	CAGR 3-Years 54%	CAGR 5-Years 31%	CAGR 10-Years 34%

See Also

Based on the financial report for Mar 31, 2023, Jbm (Healthcare) Ltd's Revenue amounts to 520.3m HKD.

Over the last year, the Revenue growth was 28%. The average annual Revenue growth rates for Jbm (Healthcare) Ltd have been 11% over the past three years , 15% over the past five years .

Join more than 134,400+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.